Assessing the acceptability and feasibility of remote spirometric monitoring for rural patients with interstitial lung disease: a multimethod approach

Ryan D. Boente,Sydney Schacht,Rebecca Borton,Joseph Vincent,Lilian Golzarri-Arroyo,Nicholas Rattray
DOI: https://doi.org/10.1186/s12931-024-02735-z
IF: 5.8
2024-02-21
Respiratory Research
Abstract:Interstitial lung disease encompasses a group of rare lung conditions causing inflammation and scarring of lung tissue. The typical method of monitoring disease activity is through pulmonary function tests performed in a hospital setting. However, accessing care can be difficult for rural patients due to numerous barriers. This study assesses the feasibility and acceptability of home spirometry telemonitoring using MIR-Spirometers and the patientMpower home-monitoring platform for rural patients with interstitial lung disease.
respiratory system
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to evaluate whether remote pulmonary function monitoring is feasible and acceptable for patients with interstitial lung disease (ILD) living in rural areas. Specifically, the study focuses on the following aspects: 1. **Feasibility**: By using Bluetooth - enabled MIR - Spirometers and web - based platforms to monitor the pulmonary function of ILD patients in rural areas, evaluate the compliance of these patients in conducting home pulmonary function tests twice a week. 2. **Acceptability**: Evaluate the attitudes and experiences of rural patients towards remote patient monitoring, and identify the barriers and facilitators in using remote monitoring technology in clinical care. ### Research Background Interstitial lung disease (ILD) is a group of rare lung diseases characterized by inflammation and scar formation in lung tissue. Usually, the method for monitoring ILD activity is to conduct pulmonary function tests (PFTs) in a hospital environment, which requires patients to have frequent contact with the medical team. However, for patients living in rural areas, it is very difficult to obtain professional care due to factors such as distance, time, and cost. Therefore, remote monitoring technology provides a potential solution to improve the accessibility of care for these patients. ### Research Methods - **Design**: Single - arm, prospective, multi - method study. - **Sample**: 20 rural ILD patients who meet the inclusion criteria. - **Interventions**: Participants received training on how to download and use web - based applications, pair Bluetooth pulmonary function meters, and interact with the devices. They were required to conduct pulmonary function tests at least twice a week and complete relevant patient - reported outcome questionnaires. - **Data Collection**: Baseline demographic and clinical data were collected through electronic medical record review. During the study, the results of each pulmonary function test and patient - reported outcome indicators were recorded. ### Main Findings - **Compliance**: The average compliance rate of participants was 53%, and they conducted an average of 2.26 pulmonary function tests per week. There were large differences in compliance among individuals. - **Attitudes and Experiences**: Most participants had a positive attitude towards remote monitoring, believing that it improved the accessibility of care and enabled them to better manage their own diseases. The main barriers included travel distance, cost, and the lack of local professional care resources. ### Conclusions Remote pulmonary function monitoring through web - based telemedicine is feasible and acceptable for rural ILD patients. Although there are some challenges in terms of technology and infrastructure, overall, this monitoring method helps to overcome the barriers to accessing care. Future research needs to further explore long - term feasibility and the comparative effectiveness with routine care. In addition, issues such as cost, reimbursement, and Internet access need to be addressed to achieve more widespread implementation.